Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne M Crowe

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Plos One|February 2, 2017
High Levels of Transmitted HIV Drug Resistance in a Study in Papua New GuineaEvelyn Lavu, Ellan Kave, Euodia Mosoro, et al.
Journal of Clinical Microbiology|February 1, 2019
Performance of a Novel Low-Cost, Instrument-Free Plasma Separation Device for HIV Viral Load Quantification and Determination of Treatment Failure in People Living with HIV in Malaysia: a Diagnostic Accuracy StudyMinh D Pham, Berhan A Haile, Iskandar Azwa, et al.
Clinical Immunology (Orlando, Fla.)|August 11, 2010
Extremely prolonged HIV seroconversion associated with an MHC haplotype carrying disease susceptibility genes for antibody deficiency disordersAlex Padiglione, Eman Aleksic, Martyn French, et al.
Immunology and Cell Biology|December 4, 2013
Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV-positive individualsClare L V Westhorpe, Anna Maisa, Tim Spelman, et al.
Journal of Clinical Microbiology|December 8, 2005
Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assayCheryl Jennings, Susan A Fiscus, Suzanne M Crowe, et al.
Retrovirology|September 25, 2007
Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivoPaul R Gorry, Dale A McPhee, Erin Verity, et al.
The Journal of Infectious Diseases|January 11, 2013
Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated agingEdwin Leeansyah, Paul U Cameron, Ajantha Solomon, et al.
AIDS (London, England)|March 31, 2017
Major health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapyReena Rajasuriar, Meng L Chong, Nor S Ahmad Bashah, et al.
Virology|January 24, 2007
Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygotePaul R Gorry, Rebecca L Dunfee, Megan E Mefford, et al.
AIDS (London, England)|November 12, 2016
Increased glucose transporter-1 expression on intermediate monocytes from HIV-infected women with subclinical cardiovascular diseaseTiffany R Butterfield, David B Hanna, Robert C Kaplan, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Plos One|February 2, 2017
High Levels of Transmitted HIV Drug Resistance in a Study in Papua New GuineaEvelyn Lavu, Ellan Kave, Euodia Mosoro, et al.
Journal of Clinical Microbiology|February 1, 2019
Performance of a Novel Low-Cost, Instrument-Free Plasma Separation Device for HIV Viral Load Quantification and Determination of Treatment Failure in People Living with HIV in Malaysia: a Diagnostic Accuracy StudyMinh D Pham, Berhan A Haile, Iskandar Azwa, et al.
Clinical Immunology (Orlando, Fla.)|August 11, 2010
Extremely prolonged HIV seroconversion associated with an MHC haplotype carrying disease susceptibility genes for antibody deficiency disordersAlex Padiglione, Eman Aleksic, Martyn French, et al.
Immunology and Cell Biology|December 4, 2013
Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV-positive individualsClare L V Westhorpe, Anna Maisa, Tim Spelman, et al.
Journal of Clinical Microbiology|December 8, 2005
Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assayCheryl Jennings, Susan A Fiscus, Suzanne M Crowe, et al.
Retrovirology|September 25, 2007
Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivoPaul R Gorry, Dale A McPhee, Erin Verity, et al.
The Journal of Infectious Diseases|January 11, 2013
Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated agingEdwin Leeansyah, Paul U Cameron, Ajantha Solomon, et al.
AIDS (London, England)|March 31, 2017
Major health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapyReena Rajasuriar, Meng L Chong, Nor S Ahmad Bashah, et al.
Virology|January 24, 2007
Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygotePaul R Gorry, Rebecca L Dunfee, Megan E Mefford, et al.
AIDS (London, England)|November 12, 2016
Increased glucose transporter-1 expression on intermediate monocytes from HIV-infected women with subclinical cardiovascular diseaseTiffany R Butterfield, David B Hanna, Robert C Kaplan, et al.
Pageof 15